{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-138796","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.357748+00:00","generated_at":"2026-05-19T14:08:34.690837+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"AN2 Therapeutics posts updated investor presentation with no new material facts","bullets":["Filed 8-K under Item 7.01 furnishing an updated investor presentation dated June 2025.","No specific financial results, pipeline updates, or guidance changes disclosed in the filing.","Presentation available on the 'Investors' section of the company's website.","No material information beyond the routine investor update was provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-138796","json":"https://secwatch.observer/filing/0001193125-25-138796.json","markdown":"https://secwatch.observer/filing/0001193125-25-138796.md","text":"https://secwatch.observer/filing/0001193125-25-138796.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525138796/0001193125-25-138796-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525138796/d812980d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T14:08:34.690837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}